Highlights from the 14th St Gallen International Breast Cancer Conference 2015 in Vienna: Dealing with classification, prognostication, and prediction refinement to personalize the treatment of patients with early breast cancer
2015-01-01 Esposito, Angela; Criscitiello, Carmen; Curigliano, Giuseppe
Tucatinib approval by EMA expands options for HER2-positive locally advanced or metastatic breast cancer
2021-01-01 Corti, C; Criscitiello, C
Surgery of the primary tumor in de novo metastatic breast cancer: To do or not to do?
2015-01-01 Criscitiello, C; Giuliano, M; Curigliano, G; De Laurentiis, M; Arpino, G; Carlomagno, N; De Placido, S; Golshan, M; Santangelo, M
Gene modules and response to neoadjuvant chemotherapy in breast cancer subtypes: a pooled analysis
2012-01-01 Ignatiadis, M; Singhal, Sk; Desmedt, C; Haibe-Kains, B; Criscitiello, C; Andre, F; Loi, S; Piccart, M; Michiels, S; Sotiriou, C
ESMO Management and treatment adapted recommendations in the COVID-19 era: Breast Cancer
2020-01-01 De Azambuja, E.; Trapani, D.; Loibl, S.; Delaloge, S.; Senkus, E.; Criscitiello, C.; Poortman, P.; Gnant, M.; Di Cosimo, S.; Cortes, J.; Cardoso, F.; Paluch-Shimon, S.; Curigliano, G.
Immunotherapy addition to neoadjuvant chemotherapy for early triple negative breast cancer: A systematic review and meta-analysis of randomized clinical trials
2021-01-01 Tarantino, P.; Gandini, S.; Trapani, D.; Criscitiello, C.; Curigliano, G.
Antiangiogenic therapy in recurrent breast cancer with lymphangitic spread to the chest wall: A randomized phase II trial of bevacizumab with sequential or concurrent oral vinorelbine and capecitabine
2015-01-01 Curigliano, G; Bagnardi, V; Bertolini, F; Alcalay, M; Locatelli, Ma; Fumagalli, L; Rabascio, C; Calleri, A; Adamoli, L; Criscitiello, C; Viale, G; Goldhirsch, A
Investigational platelet-derived growth factor receptor kinase inhibitors in breast cancer therapy
2014-01-01 Criscitiello, C.; Gelao, L.; Viale, G.; Esposito, A.; Curigliano, G.
Mismatch repair (MMR) and microsatellite instability (MSI) phenotypes across solid tumors: A comprehensive cBioPortal study on prevalence and prognostic impact
2025-01-01 Venetis, Konstantinos; Frascarelli, Chiara; Bielo, Luca Boscolo; Cursano, Giulia; Adorisio, Riccardo; Ivanova, Mariia; Mane, Eltjona; Peruzzo, Virginia; Concardi, Alberto; Negrelli, Mariachiara; D'Ercole, Marianna; Porta, Francesca Maria; Zhan, Yinxiu; Marra, Antonio; Trapani, Dario; Criscitiello, Carmen; Curigliano, Giuseppe; Guerini-Rocco, Elena; Fusco, Nicola
Tumor-infiltrating lymphocytes in breast cancer according to tumor subtype: Current state of the art
2017-01-01 Solinas, Cinzia; Carbognin, Luisa; De Silva, Pushpamali; Criscitiello, Carmen; Lambertini, Matteo
Association between baseline tumour burden and outcome in patients with cancer treated with next-generation immunoncology agents
2020-01-01 Tarantino, P.; Marra, A.; Gandini, S.; Minotti, M.; Pricolo, P.; Signorelli, G.; Criscitiello, C.; Locatelli, M.; Belli, C.; Bellomi, M.; Curigliano, G.
Immune-Related Adverse Event Likelihood Score Identifies “Pure” IRAEs Strongly Associated With Outcome in a Phase I-II Trial Population
2024-01-01 Mazzarella, Luca; Giugliano, Federica; Nicolo, Eleonora; Esposito, Angela; Crimini, Edoardo; Tini, Giulia; Uliano, Jacopo; Corti, Chiara; D'Amico, Paolo; Aliaga, Pamela Trillo; Valenza, Carmine; Repetto, Matteo; Antonarelli, Gabriele; Ascione, Liliana; Vivanet, Grazia; Berton Giachetti, Pier Paolo Maria; Minchella, Ida; Belli, Carmen; Locatelli, Marzia; Criscitiello, Carmen; Curigliano, Giuseppe
Targeting fibroblast growth factor receptor pathway in breast cancer
2015-01-01 Criscitiello, C.; Esposito, A.; De Placido, S.; Curigliano, G.
Maximizing the Clinical Benefit of Anthracyclines in Addition to Taxanes in the Adjuvant Treatment of Early Breast Cancer
2017-01-01 Curigliano, G.; Criscitiello, C.
Efficacy of Antiresorptive Drugs on Bone Mineral Density in Post-Menopausal Women With Early Breast Cancer Receiving Adjuvant Aromatase Inhibitors: A Systematic Review of Randomized Controlled Trials
2022-01-01 De Sire, A.; Lippi, L.; Venetis, K.; Morganti, S.; Sajjadi, E.; Curci, C.; Ammendolia, A.; Criscitiello, C.; Fusco, N.; Invernizzi, M.
Molecular tumour board at European Institute of Oncology: Report of the first three year activity of an Italian precision oncology experience
2023-01-01 Repetto, Matteo; Crimini, Edoardo; Boscolo Bielo, Luca; Guerini-Rocco, Elena; Ascione, Liliana; Bonfanti, Andrea; Zanzottera, Cristina; Mazzarella, Luca; Ranghiero, Alberto; Belli, Carmen; Criscitiello, Carmen; Esposito, Angela; Barberis, Massimo C. P.; Curigliano, Giuseppe
Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: young oncologists’ perspective
2020-01-01 Lambertini, Matteo; Toss, Angela; Passaro, Antonio; Criscitiello, Carmen; Cremolini, Chiara; Cardone, Claudia; Loupakis, Fotios; Viscardi, Giuseppe; Meattini, Icro; Dieci, Maria Vittoria; Ferrara, Roberto; Giusti, Raffaele; Di Maio, Massimo
HER2 signaling pathway and trastuzumab cardiotoxicity
2013-01-01 Criscitiello, C.; Curigliano, G.
Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies
2020-01-01 Marra, A.; Trapani, D.; Viale, G.; Criscitiello, C.; Curigliano, G.
Best management of locally advanced inoperable breast cancer
2013-01-01 Curigliano, G; Criscitiello, C; Esposito, A; Fumagalli, L; Gelao, L; Locatelli, M; Minchella, I; Goldhirsch, A
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Highlights from the 14th St Gallen International Breast Cancer Conference 2015 in Vienna: Dealing with classification, prognostication, and prediction refinement to personalize the treatment of patients with early breast cancer | 1-gen-2015 | Esposito, Angela; Criscitiello, Carmen; Curigliano, Giuseppe | |
| Tucatinib approval by EMA expands options for HER2-positive locally advanced or metastatic breast cancer | 1-gen-2021 | Corti, C; Criscitiello, C | |
| Surgery of the primary tumor in de novo metastatic breast cancer: To do or not to do? | 1-gen-2015 | Criscitiello, C; Giuliano, M; Curigliano, G; De Laurentiis, M; Arpino, G; Carlomagno, N; De Placido, S; Golshan, M; Santangelo, M | |
| Gene modules and response to neoadjuvant chemotherapy in breast cancer subtypes: a pooled analysis | 1-gen-2012 | Ignatiadis, M; Singhal, Sk; Desmedt, C; Haibe-Kains, B; Criscitiello, C; Andre, F; Loi, S; Piccart, M; Michiels, S; Sotiriou, C | |
| ESMO Management and treatment adapted recommendations in the COVID-19 era: Breast Cancer | 1-gen-2020 | De Azambuja, E.; Trapani, D.; Loibl, S.; Delaloge, S.; Senkus, E.; Criscitiello, C.; Poortman, P.; Gnant, M.; Di Cosimo, S.; Cortes, J.; Cardoso, F.; Paluch-Shimon, S.; Curigliano, G. | |
| Immunotherapy addition to neoadjuvant chemotherapy for early triple negative breast cancer: A systematic review and meta-analysis of randomized clinical trials | 1-gen-2021 | Tarantino, P.; Gandini, S.; Trapani, D.; Criscitiello, C.; Curigliano, G. | |
| Antiangiogenic therapy in recurrent breast cancer with lymphangitic spread to the chest wall: A randomized phase II trial of bevacizumab with sequential or concurrent oral vinorelbine and capecitabine | 1-gen-2015 | Curigliano, G; Bagnardi, V; Bertolini, F; Alcalay, M; Locatelli, Ma; Fumagalli, L; Rabascio, C; Calleri, A; Adamoli, L; Criscitiello, C; Viale, G; Goldhirsch, A | |
| Investigational platelet-derived growth factor receptor kinase inhibitors in breast cancer therapy | 1-gen-2014 | Criscitiello, C.; Gelao, L.; Viale, G.; Esposito, A.; Curigliano, G. | |
| Mismatch repair (MMR) and microsatellite instability (MSI) phenotypes across solid tumors: A comprehensive cBioPortal study on prevalence and prognostic impact | 1-gen-2025 | Venetis, Konstantinos; Frascarelli, Chiara; Bielo, Luca Boscolo; Cursano, Giulia; Adorisio, Riccardo; Ivanova, Mariia; Mane, Eltjona; Peruzzo, Virginia; Concardi, Alberto; Negrelli, Mariachiara; D'Ercole, Marianna; Porta, Francesca Maria; Zhan, Yinxiu; Marra, Antonio; Trapani, Dario; Criscitiello, Carmen; Curigliano, Giuseppe; Guerini-Rocco, Elena; Fusco, Nicola | |
| Tumor-infiltrating lymphocytes in breast cancer according to tumor subtype: Current state of the art | 1-gen-2017 | Solinas, Cinzia; Carbognin, Luisa; De Silva, Pushpamali; Criscitiello, Carmen; Lambertini, Matteo | |
| Association between baseline tumour burden and outcome in patients with cancer treated with next-generation immunoncology agents | 1-gen-2020 | Tarantino, P.; Marra, A.; Gandini, S.; Minotti, M.; Pricolo, P.; Signorelli, G.; Criscitiello, C.; Locatelli, M.; Belli, C.; Bellomi, M.; Curigliano, G. | |
| Immune-Related Adverse Event Likelihood Score Identifies “Pure” IRAEs Strongly Associated With Outcome in a Phase I-II Trial Population | 1-gen-2024 | Mazzarella, Luca; Giugliano, Federica; Nicolo, Eleonora; Esposito, Angela; Crimini, Edoardo; Tini, Giulia; Uliano, Jacopo; Corti, Chiara; D'Amico, Paolo; Aliaga, Pamela Trillo; Valenza, Carmine; Repetto, Matteo; Antonarelli, Gabriele; Ascione, Liliana; Vivanet, Grazia; Berton Giachetti, Pier Paolo Maria; Minchella, Ida; Belli, Carmen; Locatelli, Marzia; Criscitiello, Carmen; Curigliano, Giuseppe | |
| Targeting fibroblast growth factor receptor pathway in breast cancer | 1-gen-2015 | Criscitiello, C.; Esposito, A.; De Placido, S.; Curigliano, G. | |
| Maximizing the Clinical Benefit of Anthracyclines in Addition to Taxanes in the Adjuvant Treatment of Early Breast Cancer | 1-gen-2017 | Curigliano, G.; Criscitiello, C. | |
| Efficacy of Antiresorptive Drugs on Bone Mineral Density in Post-Menopausal Women With Early Breast Cancer Receiving Adjuvant Aromatase Inhibitors: A Systematic Review of Randomized Controlled Trials | 1-gen-2022 | De Sire, A.; Lippi, L.; Venetis, K.; Morganti, S.; Sajjadi, E.; Curci, C.; Ammendolia, A.; Criscitiello, C.; Fusco, N.; Invernizzi, M. | |
| Molecular tumour board at European Institute of Oncology: Report of the first three year activity of an Italian precision oncology experience | 1-gen-2023 | Repetto, Matteo; Crimini, Edoardo; Boscolo Bielo, Luca; Guerini-Rocco, Elena; Ascione, Liliana; Bonfanti, Andrea; Zanzottera, Cristina; Mazzarella, Luca; Ranghiero, Alberto; Belli, Carmen; Criscitiello, Carmen; Esposito, Angela; Barberis, Massimo C. P.; Curigliano, Giuseppe | |
| Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: young oncologists’ perspective | 1-gen-2020 | Lambertini, Matteo; Toss, Angela; Passaro, Antonio; Criscitiello, Carmen; Cremolini, Chiara; Cardone, Claudia; Loupakis, Fotios; Viscardi, Giuseppe; Meattini, Icro; Dieci, Maria Vittoria; Ferrara, Roberto; Giusti, Raffaele; Di Maio, Massimo | |
| HER2 signaling pathway and trastuzumab cardiotoxicity | 1-gen-2013 | Criscitiello, C.; Curigliano, G. | |
| Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies | 1-gen-2020 | Marra, A.; Trapani, D.; Viale, G.; Criscitiello, C.; Curigliano, G. | |
| Best management of locally advanced inoperable breast cancer | 1-gen-2013 | Curigliano, G; Criscitiello, C; Esposito, A; Fumagalli, L; Gelao, L; Locatelli, M; Minchella, I; Goldhirsch, A |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista26266
Data di pubblicazione
- In corso di stampa10
- 2020 - 20268444
- 2010 - 201911540
- 2000 - 20094513
- 1990 - 19991428
- 1980 - 1989308
- 1975 - 197923
Editore
- Edition AERCV1
- Elsevier1
- Futura Publishing Company1
- Grafica Luigi Monti s.r.l.1
- Karger, Basel1
- Mosby1
- sn1
- Springer-Verlag1
- Thieme1
Rivista
- DIGESTIVE AND LIVER DISEASE358
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...259
- ANNALS OF ONCOLOGY239
- CANCERS223
- THE JOURNAL OF NUCLEAR MEDICINE221
- PLOS ONE211
- EUROPEAN JOURNAL OF CANCER197
- GASTROINTESTINAL ENDOSCOPY193
- ALLERGY178
- JOURNAL OF CLINICAL ONCOLOGY169
Keyword
- Humans2102
- Female1005
- Male964
- Middle Aged745
- Aged643
- Adult550
- COVID-19408
- Treatment Outcome359
- Animals321
- Retrospective Studies262
Lingua
- eng18439
- ita405
- spa13
- fre11
- ger8
- enm3
- por2
- chi1
- und1
Accesso al fulltext
- no fulltext24066
- reserved1312
- open888